Low Molecular Weight Heparin as an Alternative to Unfractionated Heparin in the Immediate Postoperative Period After Left Ventricular Assist Device Implantation
- 22 October 2008
- journal article
- clinical trial
- Published by Wiley in Artificial Organs
- Vol. 32 (10), 819-822
- https://doi.org/10.1111/j.1525-1594.2008.00634.x
Abstract
We present a regimen for anticoagulation in the immediate postoperative period after left ventricular assist device (LVAD) implantation using low molecular weight heparin (LMWH) as an alternative to unfractionated heparin. Between May and September 2007, eight consecutive patients undergoing LVAD implantation for advanced heart failure received the LMWH nadroparin. Nadroparin was given twice daily to achieve anti‐Factor Xa activity target peak levels of 0.4 ± 0.1 U/mL. The antiplatelet therapy consisted of aspirin (100 mg/day) and dipyridamole (3 × 75 mg/day). One patient underwent heart transplantation, three patients died, and four patients continued to receive device support. The median duration of support was 78 days (range, 46 to 174). No major bleeding was observed; minor bleeding occurred in three patients. In two patients, pump thrombosis was suspected. There were two ischemic and no hemorrhagic strokes. The use of LMWH may provide a new anticoagulation treatment option in the immediate postoperative period after LVAD implantation.Keywords
This publication has 9 references indexed in Scilit:
- Beyond Unfractionated Heparin and WarfarinCirculation, 2007
- Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysisEuropean Heart Journal, 2007
- Long‐term Management of an Implantable Left Ventricular Assist Device Using Low Molecular Weight Heparin and Antiplatelet Therapy: A Possible Alternative to Oral AnticoagulantsArtificial Organs, 2007
- Management of Venous Thromboembolism: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family PhysiciansAnnals of Internal Medicine, 2007
- Subcutaneous Low Molecular Weight Heparin for Management of Anticoagulation in Infants on Excor Ventricular Assist DeviceAsaio Journal, 2006
- Early Postoperative Anticoagulation After Mechanical Valve Replacement: A Systematic ReviewThe Annals of Thoracic Surgery, 2006
- Management of Intracranial Hemorrhage in Patients with Mechanical Circulatory Support: A Role for Low-Molecular-Weight Heparins?Asaio Journal, 2005
- Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantationThe American Journal of Cardiology, 2004
- Low Molecular Weight Heparin After Mechanical Heart Valve ReplacementCirculation, 2000